Early treatment with eculizumab in atypical haemolytic uraemic syndrome

Atypical haemolytic uraemic syndrome (aHUS) is a rare and life-threatening disease caused by complement system dysregulation leading to uncontrolled complement activation and thrombotic microangiopathy. We report the case of an adult patient with plasmaphaeresis-resistant aHUS and hypertension treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Garjau, Maria, Azancot, María, Ramos, Rosa, Sánchez-Corral, Pilar, Montero, Maria Angeles, Serón, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Clinical Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400458/
https://www.ncbi.nlm.nih.gov/pubmed/26069743
http://dx.doi.org/10.1093/ndtplus/sfr157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400458/
https://www.ncbi.nlm.nih.gov/pubmed/26069743
http://dx.doi.org/10.1093/ndtplus/sfr157

Ejemplares similares